Surging Healthcare Expenditure Boosted the Global Hemophilia Market
The global hemophilia market is anticipated to reach US$13.86 billion 2024, growing at a CAGR of 5.61% during the period spanning 2020-2024. The growth in the market has been driven by factors like increasing healthcare expenditure and surging identified hemophilia patient volume. The market is expected to face certain challenges such as high cost of treatment and reluctance to switch to newer ..